SEC filings
Quest Diagnostics (DGX)
Recent filings Quest Diagnostics made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001022079All filings on SEC.gov
10-QQuarterly report
Quarterly report
Quest Diagnostics reported third-quarter 2026 net revenues of $3.097 billion, up 10.0% from a year earlier, with net income attributable to the company of $312 million and diluted earnings per share of $2.78. …
8-KCurrent report
Other Events
Quest Diagnostics learned on October 21, 2026 of unauthorized access to its Quanum LSM system, which clients use to place test orders and receive and look up results, and believes an unauthorized party accessed certain patient records. …
8-KCurrent report
Results of Operations and Financial Condition
Quest Diagnostics reported third-quarter 2026 revenues of $3.10 billion, up 10.0% from a year earlier, with reported diluted EPS of $2.78 and adjusted diluted EPS of $3.00, and raised its full-year 2026 revenue and EPS guidance. …
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Quest Diagnostics announced that Catherine T. Doherty will retire in July 2027, transitioning effective November 1, 2026 to an Executive Vice President role covering health systems, the company's joint venture with Corewell Health, and…
10-QQuarterly report
Quarterly report
Quest Diagnostics reported second-quarter 2026 net revenues of $3.04 billion, up 10.2% year over year, and diluted earnings per share of $2.84, up 15.0%, with test volume growth of 13.1% attributed in part to a new relationship with…
8-KCurrent report
Results of Operations and Financial Condition
Quest Diagnostics reported second-quarter 2026 net revenues of $3.04 billion, up 10.2% from a year earlier, and adjusted diluted EPS of $3.12, up 19.1%, and raised its full-year 2026 revenue and EPS guidance. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Quest Diagnostics in Readster
Add Quest Diagnostics to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.